Core Points - The China Securities Hong Kong Stock Connect Medical Comprehensive Index (932271) opened at 1310.24 points, showing a decline of 15.51% over the past month, an increase of 7.01% over the past three months, and a year-to-date increase of 1.58% [1] - The index is compiled based on the classification standards of the China Securities Index, reflecting the overall performance of different industry securities within the Hong Kong Stock Connect [1] - The top ten holdings of the index include Alibaba Health (14.23%), JD Health (14.01%), Sinopharm (12.15%), Weigao Group (7.98%), MicroPort Medical (5.06%), Ping An Good Doctor (4.48%), Shanghai Pharmaceuticals (4.05%), Jinxin Fertility (3.72%), Xianjian Technology (3.29%), and MicroPort Robotics-B (3.28%) [1] Industry Composition - The index's holdings are entirely from the Hong Kong Stock Exchange, with the pharmaceutical commercial sector accounting for 46.78%, medical services for 24.51%, medical consumables for 24.08%, medical devices for 3.70%, and in vitro diagnostics for 0.92% [2] - The index samples are adjusted biannually, with adjustments occurring on the next trading day after the second Friday of June and December each year [2] - Weight factors are generally fixed until the next scheduled adjustment, with provisions for temporary adjustments in case of special events affecting the index sample [2]

Core Viewpoint - The China Securities Index for the medical industry has shown a slight decline over the past month, quarter, and year-to-date, indicating a stable but slightly negative trend in the sector [2]. Group 1: Index Performance - The China Securities Index for the medical industry is currently at 566.67 points [1]. - Over the past month, the index has decreased by 0.49%, while it has seen a minimal decline of 0.02% over the past three months and year-to-date [2]. Group 2: Index Composition - The top ten weighted companies in the index include: - Mindray Medical (14.12%) - Aier Eye Hospital (8.91%) - United Imaging Healthcare (7.39%) - Aimeike (3.93%) - Huatai Medical (3.48%) - New Industries (3.41%) - Yuyue Medical (3.12%) - Shanghai Pharmaceuticals (3.04%) - Meinian Onehealth (2.57%) - Jiuan Medical (2.39%) [2]. - The index's holdings are primarily listed on the Shenzhen Stock Exchange (57.38%) and the Shanghai Stock Exchange (42.62%) [2]. Group 3: Sector Allocation - The sector allocation within the index is as follows: - Medical Devices: 34.29% - Medical Consumables: 23.16% - Pharmaceutical Commerce: 15.33% - Medical Services: 14.26% - In Vitro Diagnostics: 12.95% [2]. Group 4: Index Adjustment Mechanism - The index samples are adjusted biannually, with adjustments occurring on the next trading day following the second Friday of June and December [3]. - Weight factors are generally fixed until the next scheduled adjustment, with temporary adjustments made in response to significant events affecting sample companies [3].